查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403461

2030 年微生物組定序服務市場預測：按類型、服務、技術、應用、最終用戶和地區進行的全球分析

Microbiome Sequencing Services Market Forecasts to 2030 - Global Analysis By Type, Service, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球微生物組定序服務市場規模將達到 15.4 億美元，預計到 2030 年將達到 36.1 億美元，預測期內複合年成長率為 12.9%。

微生物組定序服務分析樣本中微生物的 DNA，揭示生活在特定環境（例如人類腸道）中的不同微生物群落的詳細資訊。這對於推進個人化醫療、疾病診斷以及理解微生物組與各種生態系統之間複雜的相互作用至關重要。這些服務可識別和量化微生物種類，並幫助研究人員和臨床醫生了解微生物組的組成和功能。

澳洲癌症協會2022年資料更新估計，2022年澳洲將新診斷出162,163例癌症病例，其中男性88,982例，女性73,181例。

擴大生物製藥研究

生物製藥公司越來越認知到微生物組在人類健康和疾病中發揮的關鍵作用，為標靶治療和精準醫療方法的發展鋪平了道路。生物製藥公司正在利用微生物組定序進行臨床前和臨床試驗，以了解治療治療性介入對微生物生態系統的影響。此外，對腸道微生物組的探索尤其因其調節藥物代謝、功效和安全性的潛力而受到關注，從而推動了該市場的規模。

高成本

小型研究機構、學術實驗室和新興企業面臨獨特的財務挑戰，由於成本高昂，他們無法徹底實施微生物組定序服務。這些高成本加劇了研究人員和組織的經濟障礙，包括樣本採集、DNA 提取、文庫製備和資料分析。此外，微生物組分析的複雜性需要先進的定序技術和生物資訊學知識，增加了這些服務的整體高成本，阻礙了該市場的規模。

定序技術創新

技術的進步使研究人員能夠產生大量資料，有助於更全面地了解不同生態系統中的微生物群落。次世代定序儀（NGS）平台、Illumina和Thermo Fisher等技術大大增加了微生物組定序的深度和廣度。此外，提高的定序準確性、更長的讀長和增加的通量有助於識別和表徵更廣泛的微生物物種，從而推動該市場的擴張。

與標準化相關的風險

不同平台和服務供應商之間的協議、方法和資料分析程序缺乏統一性，為比較和解釋結果帶來了挑戰。這種變異性可能導致微生物群落分析的不一致。此外，缺乏樣本採集、DNA 萃取和定序文庫製備的標準化方法可能會對微生物組資料造成偏差和錯誤。這不僅影響學術研究，也影響微生物組定序向臨床應用和法律規範的過渡，阻礙市場成長。

COVID-19 的影響

COVID-19 的爆發以多種方式對微生物組定序服務市場產生了負面影響。供應鏈中斷、物流挑戰和實驗室活動限制阻礙了微生物組定序服務的無縫運作。許多研究機構和生技公司面臨財務困難，進一步限制了微生物組研究和定序服務的投資。此外，臨床試驗和學術研究活動減少了學術和工業環境中對微生物組定序服務的需求，阻礙了該市場的成長。

全基因組定序部分預計在預測期內規模最大

全基因組定序領域預計將在估計和預測期間佔據最大佔有率，因為它能夠獲得廣泛的遺傳資訊，從而能夠檢測微生物群落內的稀有物種和變異。此外，該技術還能對生物體的整個 DNA 進行定序，從而可以詳細了解其基因組成、功能元件和潛在的毒力因子。該技術有助於加速發現並指導治療性介入，從而推動該領域的成長。

連接定序（SBL）領域預計在預測期內複合年成長率最高

連接定序（SBL）領域預計在預測期內複合年成長率最高。在 SBL 中，DNA 片段使用特定的接頭連接形成串聯結構。這提供了諸如高精度、長讀長以及從困難的基因組區域檢索資訊的能力等優點。此外，研究人員和服務供應商可以全面了解微生物基因組，幫助了解群落動態、功能潛力和宿主-微生物組相互作用。

比最大的地區

人們越來越認知到微生物組對健康和疾病的影響，再加上精準醫療和個體化醫療保健的重要性日益增加，在估計期間佔據了最大的市場佔有率。中國、日本、韓國和印度等國家正在促進研究機構、生技公司和定序服務供應商之間的合作。此外，隨著研究能力和基礎設施的不斷加強，高通量定序技術和生物資訊能力的進步進一步推動了該地區的成長。

複合年成長率最高的地區：

預計歐洲在預測期內的複合年成長率最高。歐洲各地的多樣化人口為微生物組研究提供了豐富的環境，使研究人員能夠研究微生物組成的變化及其對區域健康模式的影響。此外，Illumina, Inc.、Macrogen, Inc.、Genewiz 和 Eurofins Scientific 等主要企業為個人化醫療、農業實踐和對微生物生態系統的了解做出了重大貢獻，正在推動該地區的擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球微生物組定序服務市場：按類型

  • 霰彈槍序列
  • 全基因組序列測定
  • 放大器序列測定
  • 其他類型

第6章全球微生物組定序服務市場：依服務分類

  • 資料分析
  • 樣品製備
  • 序列庫的製備
  • 其他服務

第7章全球微生物組定序服務市場：依技術分類

  • 標靶基因序列測定
  • 連接定序 (SBL)
  • 合成定序(SBS)
  • 其他技術

第8章全球微生物組定序服務市場：依應用分類

  • 中樞神經系統疾病
  • 腫瘤學
  • 消化系統疾病
  • 感染疾病
  • 其他用途

第9章全球微生物組定序服務市場：依最終用戶分類

  • 學術研究所
  • 製藥和生物技術公司
  • 其他最終用戶

第10章全球微生物組定序服務市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • DNA Genotek Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Metabiomics
  • CosmosID
  • Zymo Research Corporation
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd.
  • Rancho Biosciences
  • Baseclear BV
  • Diversigen, Inc.
  • Merieux Nutrisciences Corporations
  • Clinical Microbiomics AS
  • Bio-Rad Laboratories, Inc.
  • Genewiz Inc.
Product Code: SMRC24686

According to Stratistics MRC, the Global Microbiome Sequencing Services Market is accounted for $1.54 billion in 2023 and is expected to reach $3.61 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Microbiome sequencing services analyze the DNA of microorganisms in a sample to reveal details about the diverse community of microbes living in a particular environment, like the human gut. It is crucial for personalized medicine, disease diagnostics, and advancing our understanding of the intricate interplay between microbiota and various ecosystems. These services identify and quantify microbial species, helping researchers and clinicians understand the microbiome's composition and function.

According to the data updated by Cancer Australia in 2022, it was estimated that 162,163 new cases of cancer would be diagnosed in Australia in 2022, out of which 88,982 would be males and 73,181 females.

Market Dynamics:

Driver:

Expanding biopharmaceutical research

Biopharmaceutical companies are increasingly recognizing the pivotal role of the microbiome in influencing human health and disease, paving the way for the development of targeted therapies and precision medicine approaches. Biopharmaceutical companies leverage microbiome sequencing to conduct preclinical and clinical trials, aiming to understand the impact of therapeutic interventions on microbial ecosystems. Furthermore, the exploration of the gut microbiome, in particular, has garnered attention for its potential in modulating drug metabolism, efficacy, and safety, which is boosting this market size.

Restraint:

High cost

Smaller research institutions, academic laboratories, and startups face unique financial challenges that prevent their capacity to conduct thorough microbiome sequencing services due to high costs. Financial obstacles for researchers and organizations are made worse by these high costs, which include sample collection, DNA extraction, library preparation, and data analysis. Additionally, the complexity of microbiome analysis, which necessitates sophisticated sequencing technologies and bioinformatics knowledge, adds to the overall high cost of these services, which is hindering this market size.

Opportunity:

Innovations in sequencing technologies

The technological strides enable researchers to generate vast amounts of data, facilitating a more comprehensive understanding of microbial communities within diverse ecosystems. Technologies such as next-generation sequencing (NGS) platforms, Illumina's, and Thermo Fisher's offerings have significantly enhanced the depth and breadth of microbiome sequencing. Furthermore, improved sequencing accuracy, longer read lengths, and increased throughput contribute to the identification and characterization of a wider range of microbial species, thereby propelling this market expansion.

Threat:

Risks associated with standardization

The lack of uniformity in protocols, methodologies, and data analysis procedures across different platforms and service providers introduces challenges in comparing and interpreting results. This variability can lead to inconsistencies in microbial community profiling. Furthermore, the absence of standardized practices in sample collection, DNA extraction, and sequencing library preparation can contribute to biases and errors in microbiome data. This not only affects academic research but also impacts the translation of microbiome sequencing into clinical applications and regulatory frameworks, hindering the market's growth.

COVID-19 Impact

The COVID-19 pandemic has negatively impacted the microbiome sequencing services market in various ways. Disruptions in supply chains, logistical challenges, and restrictions on laboratory activities have impeded the seamless operation of microbiome sequencing services. Many research institutions and biotechnology companies faced financial constraints, further limiting investments in microbiome studies and sequencing services. Additionally, clinical trials and academic research activities decreased demand for microbiome sequencing services in both academic and industrial settings, impeding this market's growth.

The whole-genome sequencing segment is expected to be the largest during the forecast period

The whole-genome sequencing segment is estimated to hold the largest share during the forecast period, due to its ability to capture a broad spectrum of genetic information, enabling the detection of rare species and variations within microbial communities. Additionally, this technique involves sequencing the entire DNA of an organism, providing a detailed understanding of its genetic makeup, functional elements, and potential virulence factors. It is instrumental in fueling discoveries and guiding therapeutic interventions, thereby driving this segment's growth.

The sequencing by ligation (SBL) segment is expected to have the highest CAGR during the forecast period

The sequencing by ligation (SBL) segment is anticipated to have highest CAGR during the forecast period. In SBL, DNA fragments are ligated together using specific adapters, forming a concatemeric structure. This offers advantages such as high accuracy, long read lengths, and the ability to capture information from challenging genomic regions. In addition, researchers and service providers obtain comprehensive insights into microbial genomes, aiding in the understanding of community dynamics, functional potential, and host-microbiome interactions, which are boosting this market expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing awareness of the microbiome's impact on health and disease, coupled with a rising emphasis on precision medicine and personalized healthcare. Countries like China, Japan, South Korea, and India foster collaborations between research institutions, biotechnology companies, and sequencing service providers. In addition, as research capabilities and infrastructure continue to strengthen the advancements in high-throughput sequencing technologies and bioinformatics capabilities further propel the region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period. The diverse population across Europe provides a rich landscape for microbiome studies, enabling researchers to explore variations in microbial compositions and their impact on regional health patterns. Key players such as Illumina, Inc., Macrogen, Inc., Genewiz, and Eurofins Scientific also contribute significantly to advancements in personalized medicine, agricultural practices, and our understanding of microbial ecosystems, thus driving this region's expansion.

Key players in the market:

Some of the key players in the Microbiome Sequencing Services Market include DNA Genotek Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Metabiomics, CosmosID, Zymo Research, Corporation, PerkinElmer, Inc., BGI Genomics Co., Ltd., Rancho Biosciences, Baseclear BV, Diversigen, Inc., Merieux Nutrisciences Corporations, Clinical Microbiomics AS, Bio-Rad Laboratories, Inc. and Genewiz Inc.

Key Developments:

In November 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies announced the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs).

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In July 2023, Bio-Rad Laboratories, Inc. announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

Types Covered:

  • Shotgun Sequencing
  • Whole-genome Sequencing
  • Amplicon Sequencing
  • Other Types

Services Covered:

  • Data Analysis
  • Sample Preparation
  • Sequencing Library Preparation
  • Other Services

Technologies Covered:

  • Targeted Gene Sequencing
  • Sequencing by Ligation (SBL)
  • Sequencing by Synthesis (SBS)
  • Other Technologies

Applications Covered:

  • CNS Diseases
  • Oncology
  • Gastrointestinal Diseases
  • Infectious Diseases
  • Other Applications

End Users Covered:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbiome Sequencing Services Market, By Type

  • 5.1 Introduction
  • 5.2 Shotgun Sequencing
  • 5.3 Whole-genome Sequencing
  • 5.4 Amplicon Sequencing
  • 5.5 Other Types

6 Global Microbiome Sequencing Services Market, By Service

  • 6.1 Introduction
  • 6.2 Data Analysis
  • 6.3 Sample Preparation
  • 6.4 Sequencing Library Preparation
  • 6.5 Other Services

7 Global Microbiome Sequencing Services Market, By Technology

  • 7.1 Introduction
  • 7.2 Targeted Gene Sequencing
  • 7.3 Sequencing by Ligation (SBL)
  • 7.4 Sequencing by Synthesis (SBS)
  • 7.5 Other Technologies

8 Global Microbiome Sequencing Services Market, By Application

  • 8.1 Introduction
  • 8.2 CNS Diseases
  • 8.3 Oncology
  • 8.4 Gastrointestinal Diseases
  • 8.5 Infectious Diseases
  • 8.6 Other Applications

9 Global Microbiome Sequencing Services Market, By End User

  • 9.1 Introduction
  • 9.2 Academic and Research Institutes
  • 9.3 Pharmaceutical and Biotechnology Companies
  • 9.4 Other End Users

10 Global Microbiome Sequencing Services Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 DNA Genotek Inc.
  • 12.2 Thermo Fisher Scientific Inc.
  • 12.3 Illumina, Inc.
  • 12.4 Metabiomics
  • 12.5 CosmosID
  • 12.6 Zymo Research Corporation
  • 12.7 PerkinElmer, Inc.
  • 12.8 BGI Genomics Co., Ltd.
  • 12.9 Rancho Biosciences
  • 12.10 Baseclear BV
  • 12.11 Diversigen, Inc.
  • 12.12 Merieux Nutrisciences Corporations
  • 12.13 Clinical Microbiomics AS
  • 12.14 Bio-Rad Laboratories, Inc.
  • 12.15 Genewiz Inc.

List of Tables

  • Table 1 Global Microbiome Sequencing Services Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 4 Global Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 5 Global Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 6 Global Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 7 Global Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 8 Global Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 9 Global Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 10 Global Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 11 Global Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 12 Global Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 14 Global Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 15 Global Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 16 Global Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 17 Global Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 18 Global Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 19 Global Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 20 Global Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 21 Global Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 22 Global Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 23 Global Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 Global Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 25 Global Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 26 Global Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 27 North America Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 28 North America Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 29 North America Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 30 North America Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 31 North America Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 32 North America Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 33 North America Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 34 North America Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 35 North America Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 36 North America Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 37 North America Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 38 North America Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 39 North America Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 40 North America Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 41 North America Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 42 North America Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 43 North America Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 44 North America Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 45 North America Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 46 North America Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 47 North America Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 48 North America Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 49 North America Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 50 North America Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 51 North America Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 52 North America Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 53 Europe Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 54 Europe Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 55 Europe Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 56 Europe Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 57 Europe Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 58 Europe Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 59 Europe Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 60 Europe Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 61 Europe Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 62 Europe Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 63 Europe Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 64 Europe Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 65 Europe Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 66 Europe Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 67 Europe Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 68 Europe Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 69 Europe Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 70 Europe Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 71 Europe Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 72 Europe Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 73 Europe Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 74 Europe Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 75 Europe Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 76 Europe Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 77 Europe Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 78 Europe Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 79 Asia Pacific Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 80 Asia Pacific Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 81 Asia Pacific Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 82 Asia Pacific Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 83 Asia Pacific Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 84 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 85 Asia Pacific Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 86 Asia Pacific Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 87 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 88 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 89 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 90 Asia Pacific Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 91 Asia Pacific Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 92 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 93 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 94 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 95 Asia Pacific Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 96 Asia Pacific Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 97 Asia Pacific Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 98 Asia Pacific Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 99 Asia Pacific Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 100 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 101 Asia Pacific Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 102 Asia Pacific Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 103 Asia Pacific Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 104 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 105 South America Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 106 South America Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 107 South America Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 108 South America Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 109 South America Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 110 South America Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 111 South America Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 112 South America Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 113 South America Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 114 South America Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 115 South America Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 116 South America Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 117 South America Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 118 South America Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 119 South America Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 120 South America Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 121 South America Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 122 South America Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 123 South America Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 124 South America Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 125 South America Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 126 South America Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 127 South America Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 128 South America Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 129 South America Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 130 South America Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 131 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 132 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 133 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 134 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 135 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 136 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 137 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 138 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 139 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 140 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 141 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 142 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 143 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 144 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 145 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 146 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 147 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 148 Middle East & Africa Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 149 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 150 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 151 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 152 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 153 Middle East & Africa Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 154 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 155 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 156 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)